Which infections can cause asymptomatic (painless) testicular atrophy and what are the recommended treatments for each?

Infections Causing Asymptomatic Testicular Atrophy and Treatment

The primary infections causing asymptomatic testicular atrophy are mumps orchitis and chronic sexually transmitted infections (particularly Chlamydia trachomatis and Neisseria gonorrhoeae), with mumps being the most well-documented cause of painless testicular atrophy occurring months after the initial infection.

Key Infections and Their Mechanisms

Mumps Orchitis

• Mumps virus causes testicular atrophy in 25-55% of affected testes, typically developing 25-230 days (mean 95.9 days) after the acute orchitis episode 1
• The atrophy occurs through hematogenous spread of the virus to testicular tissue, resulting in irreversible damage to spermatogenesis 1
• Ultrasound findings show affected testes are 23-55% smaller in volume compared to normal contralateral testes, with heterogeneous hypoechoic appearance and multiple hyperechoic islands 1
• No specific treatment exists for mumps orchitis or the resulting atrophy; prevention through MMR vaccination is the only effective strategy 1

Sexually Transmitted Infections (STIs)

Chlamydia trachomatis

• Chlamydia causes chronic asymptomatic epididymo-orchitis that can lead to testicular atrophy through persistent inflammation and damage to spermatogenesis 2
• Systematic histopathological analyses show high prevalence of asymptomatic inflammatory reactions in testicular biopsies from infertile men, with focal lymphocytic infiltrates correlating with degree of spermatogenic damage 2
• Treatment: Doxycycline 100 mg orally twice daily for 10 days PLUS Ceftriaxone 250 mg IM single dose 3
• Alternative: Azithromycin 1 g orally single dose 4

Neisseria gonorrhoeae

• Gonococcal infections can cause chronic epididymo-orchitis with potential for testicular atrophy if untreated 5
• Often coexists with chlamydial infection, requiring dual therapy 4
• Treatment: Same regimen as chlamydia (Ceftriaxone 250 mg IM single dose PLUS Doxycycline 100 mg orally twice daily for 10 days) 3

Genitourinary Tuberculosis (GUTB)

• GUTB represents 4.6% of extrapulmonary TB cases and can cause asymptomatic testicular atrophy through chronic granulomatous inflammation 4
• Results from hematogenous spread of chronic latent TB infection, with up to 15% lifetime reactivation risk 4
• Risk factors include diabetes, advanced age, immunosuppression, HIV, renal failure, and poor socioeconomic conditions 4
• Diagnosis requires high index of suspicion with microbiological, molecular, and histological testing plus imaging 4
• Treatment: Standard anti-tuberculous therapy (specific regimen not detailed in provided guidelines but requires multi-drug therapy for 6-9 months minimum)

Diagnostic Approach for Asymptomatic Cases

Clinical Evaluation

• Measure testicular volume and compare bilaterally; >20% volume difference suggests atrophy 1
• Palpate for epididymal thickening or nodularity indicating chronic inflammation 6
• Assess for oblong testicular shape rather than normal elliptical shape 1
• Check for history of systemic viral illness (mumps, even if subclinical) 1

Laboratory Testing

• Obtain nucleic acid amplification tests (NAATs) for C. trachomatis and N. gonorrhoeae from first-void urine 3
• Perform urethral Gram stain if urethritis suspected 3
• Consider TB testing (interferon-gamma release assay, acid-fast bacilli culture) if risk factors present 4
• Obtain syphilis serology and HIV testing 3

Imaging

• Ultrasound shows heterogeneous hypoechoic testicular parenchyma with hyperechoic islands in atrophic testes 1
• Color Doppler demonstrates decreased or similar vascularity compared to contralateral testis 1
• CT or MRI may be needed for suspected GUTB to assess extent of disease 4

Treatment Algorithms

For STI-Related Chronic Epididymo-Orchitis (Age <35 years)

1. Empiric treatment: Ceftriaxone 250 mg IM single dose PLUS Doxycycline 100 mg orally twice daily for 10 days 3
2. Add adjunctive measures: scrotal elevation, NSAIDs for residual inflammation 3
3. Treat sexual partners for identified or suspected STI 3
4. Reevaluate if no improvement within 3 days 3
5. If persistent swelling after completing therapy, comprehensive evaluation for other conditions including chronic orchitis 3

For Enteric Organism-Related Cases (Age >35 years)

1. Ofloxacin 300 mg orally twice daily for 10 days OR Levofloxacin 500 mg orally once daily for 10 days 3
2. Alternative: Trimethoprim-sulfamethoxazole if fluoroquinolone resistance suspected 5
3. Evaluate for bladder outlet obstruction (BPH, urethral stricture) 7, 6
4. Consider urology referral if structural abnormality identified 5

For Suspected GUTB

1. Initiate multi-drug anti-tuberculous therapy based on local resistance patterns 4
2. Coordinate with infectious disease specialist 4
3. Monitor for treatment response with serial imaging and clinical assessment 4

Critical Pitfalls to Avoid

• Do not assume testicular atrophy is always symptomatic; chronic asymptomatic orchitis is underdiagnosed and represents a significant cause of male infertility 2
• Do not treat for only 7 days; epididymo-orchitis requires 10 days of antimicrobial therapy, not shorter courses 3
• Do not use fluoroquinolones as first-line for STI-related cases in men <35 years; rising E. coli resistance makes them less reliable 7
• Do not overlook partner treatment; failure to treat sexual partners leads to reinfection and continued inflammation 3
• Do not miss mumps history; even subclinical mumps can cause delayed testicular atrophy months later 1
• Do not assume negative cultures rule out chronic orchitis; asymptomatic inflammatory infiltrates may not be culture-positive 2

Special Considerations

HIV-Infected Patients

• Use same treatment regimens as HIV-negative patients 3
• Consider fungi and mycobacteria as more likely causes in severely immunosuppressed patients 3
• Maintain higher index of suspicion for GUTB 4

Fertility Implications

• Chronic asymptomatic orchitis causes irreversible damage to spermatogenesis through exposure of germ cells to inflammatory mediators 2
• Bilateral involvement or severe unilateral atrophy significantly impacts fertility 1
• Consider semen analysis after treatment completion to assess fertility potential 2
• Refer to reproductive endocrinology if fertility concerns exist 2